-
Notable Analyst Rating Changes 2/2: (MS) (NFLX) (TJX) Upgraded; (AR) (LOGI) (TWTR) Downgraded
-
Pre-Open Stock Movers 02/02: (HNSN) (KORS) (GOOGL) (GOOG) Higher; (ZINC) (IDTI) (HEAR) Lower (more...)
-
After-Hours Stock Movers 02/01: (MAT) (PVH) (GOOGL) Higher; (IDTI) (PDLI) (RCII) Lower (more...)
-
RBC Capital Starts Kite Pharma (KITE) at Outperform
-
Kite Pharma (KITE) Says Underwriter Exercised Full Option to Purchase Additional Shares
-
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Kite Pharma (KITE) Prices 3.625M Shares Offering at $69
-
Kite Pharma Announces Pricing of Public Offering of Common Stock
-
Kite Pharma (KITE) Commences $250M Common Stock Offering
-
Kite Pharma Announces Proposed Public Offering of Common Stock
-
Kite Pharma Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 06/30: (JUNO) (WSH) (PNR) Higher; (ETRM) (APOL) (SNE) Lower (more...)
-
AbbVie (ABBV) /Pharmacyclics (PCYC) Deal Bullish for SMID Biotech and Big Drugs, Says RBC
-
Notable 52-Week Highs and Lows 1/5: (ISIS) (KITE) (IPHI) High; (CEMP) (CVEO) (P) Low

